Raising the profile of cancer of unknown primary.

Suppr

超能文献

作者信息

Oien Karin A, Evans T R Jeffry

出版信息

J Clin Oncol. 2008 Sep 20;26(27):4373-5. doi: 10.1200/JCO.2008.17.6156.

DOI:10.1200/JCO.2008.17.6156

PMID:18802148

Abstract

摘要

相似文献

Raising the profile of cancer of unknown primary.

J Clin Oncol. 2008 Sep 20;26(27):4373-5. doi: 10.1200/JCO.2008.17.6156.

The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?

Eur J Cancer. 2016 Feb;54:159-162. doi: 10.1016/j.ejca.2015.09.006. Epub 2015 Nov 19.

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

J Clin Oncol. 2008 Sep 20;26(27):4442-8. doi: 10.1200/JCO.2007.14.4378.

Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.

Clin Cancer Res. 2011 Jun 15;17(12):4063-70. doi: 10.1158/1078-0432.CCR-10-2599. Epub 2011 Apr 29.

New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.

Clin Cancer Res. 2013 Aug 1;19(15):4027-33. doi: 10.1158/1078-0432.CCR-12-3030. Epub 2013 Mar 21.

Diagnostic evaluation of patients with carcinoma of unknown primary tumor site.

Semin Oncol. 1993 Jun;20(3):244-50.

Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.

J Clin Oncol. 2013 Nov 20;31(33):e443-5. doi: 10.1200/JCO.2012.46.7910. Epub 2013 Jun 17.

Importance of laparoscopic intervention in the differential diagnosis of peritonitis carcinomatosa and tuberculous peritonitis.

Turk J Gastroenterol. 2017 Nov;28(6):528-530. doi: 10.5152/tjg.2017.17131. Epub 2017 Sep 19.

Management of peritoneal carcinomatosis of unknown primary tumor site.

Semin Oncol. 1993 Jun;20(3):268-72.

[Comparing immunohistochemical diagnosis of cancer of unknown primary with gene expression-based tumor classification].

Pathologe. 2009 Dec;30 Suppl 2:168-72. doi: 10.1007/s00292-009-1194-4.

引用本文的文献

Management of Long Bones Metastatic Disease: Concepts That We All Know but Not Always Remember.

Orthop Res Rev. 2022 Nov 10;14:393-406. doi: 10.2147/ORR.S379603. eCollection 2022.

Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.

SAGE Open Med. 2022 May 24;10:20503121221097582. doi: 10.1177/20503121221097582. eCollection 2022.

Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.

Proteomics. 2012 Apr;12(8):1253-60. doi: 10.1002/pmic.201100587.

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

EMBO Mol Med. 2012 Mar;4(3):143-59. doi: 10.1002/emmm.201100209. Epub 2012 Feb 20.

Cancer microRNAs: from subtype profiling to predictors of response to therapy.

Trends Mol Med. 2011 May;17(5):235-43. doi: 10.1016/j.molmed.2011.01.008. Epub 2011 Feb 25.

Clinical presentation of carcinoma of unknown primary: 14 years of experience.

Tumour Biol. 2011 Feb;32(1):45-51. doi: 10.1007/s13277-010-0089-6. Epub 2010 Aug 10.

Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Diagn Pathol. 2010 Jan 13;5:3. doi: 10.1186/1746-1596-5-3.

Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

J Cell Mol Med. 2010 Apr;14(4):805-17. doi: 10.1111/j.1582-4934.2010.01032.x. Epub 2010 Feb 16.

[The initial CUP situation and CUP syndrome: pathological diagnostics].

Pathologe. 2009 Dec;30 Suppl 2:161-7. doi: 10.1007/s00292-009-1193-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验